A Real-world Study of Inetetamab for First-line Treatment of MBC

Clinical trial NCT05980208 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05980208
Sponsor: Hunan Cancer Hospital
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Breast Cancer Real-world Study

Start date: 2023-09-01
Primary completion: 2025-12-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.